Agenus Inc.

Industry

  • Biotechnology
    • Large Molecule
      • Antibodies
    • Drug Discovery Technologies
  • Pharmaceuticals
    • Vaccines

Other Names/Subsidiaries

  • Antigenics
  • Aronex Pharmaceuticals
  • Agenus Royalty Fund
  • Agenus Switzerland
  • Agenus UK
  • 4-Antibody
  • AgenTus Therapeutics
  • Aquila Biopharmaceuticals
  • MiNK Therapeutics
  • PhosImmune
  • SaponiQx
See more in Biomedtracker

Latest on Agenus Inc.

Scrip

BeiGene Ends Anti-TIGIT Development In Lung Cancer

 
• By Joseph Haas

The biopharma sector saw another setback for the once-hot anti-TIGIT class on 3 April as BeiGene said it would end a Phase III trial of its antibody candidate ociperlimab (BGB-A1217) in non-small cell

Scrip

Finance Watch: Sutro Halves Workforce, Cuts Lead ADC And CEO Moves On

 
• By Mandy Jackson

Sutro Biopharma announced after the stock market closed on 13 March that as a result of a strategic portfolio review the company will end development of its one and only clinical-stage antibody drug c

Scrip

Deal Watch: FTC Keeps Current Merger Guidelines In Place, For Now

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Trump Appointee Ferguson Keeps Biden-E

Scrip

Finance Watch: As Cash Dwindles, Biotechs Cut Costs, Sell Assets, Merge, Assess Options

 
• By Mandy Jackson

The end of 2024 brought near-term cash shortfalls into focus at several biopharmaceutical companies, while others completed their assessments of potential alternatives to shutting their doors as capit